Delivery Order SPE2DB22D9239-SPE2DB24FDE99
Award Date 12/6/23
Potential Completion Date 12/28/23
Potential Value $73K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this particular...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide 20 mg vials of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $72,848.40 and a completion date of February 2, 2024. The order is for the pharmaceutical product XENPOZYME 20 MG VIALS. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceuticals and medical supplies to the federal government, particularly the Department...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency...
- This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract has a ceiling value of $72,848.30 and is a firm fixed-price delivery order for the pharmaceutical product XENPOZYME 20 MG VIALS. The contract has an ultimate completion date of September 14, 2023. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XENPOZYME 20 MG VIALS. The contract has a potential value of $72,848.30 and a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense. The company...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XENPOZYME 20MG 1EA GEN. The order is valued at $218,545.20 and is scheduled for completion on October 19, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract has a potential value of $109,272.60 and a completion date of March 7, 2024. DMS Pharmaceutical Group will provide XENPOZYME 20 MG VIALS to fulfill the agency's pharmaceutical supply needs. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA,...